Outer Membrane Vesicle-Based Nanohybrids Target Tumor-Associated Macrophages to Enhance Trained Immunity-Related Vaccine-Generated Antitumor Activity

The authors found that the trained immunity-related vaccine-mediated antitumor mechanism in MC38 tumor model was trained immunity and activated T cell response, whereas in B16-F10 tumor model it was primarily mediated by trained immunity.